When.com Web Search

  1. Ads

    related to: pharmaceutical pricing strategy pdf

Search results

  1. Results From The WOW.Com Content Network
  2. WHO/Health Action International Project on Medicine Prices ...

    en.wikipedia.org/wiki/WHO/Health_Action...

    [5]: 223 [2]: 41 Although the manufacturer's price is advised for prices analyses, it is advisable, or even key, for the design of pharmaceutical pricing policies [5]: 223 [11]: 190 to calculate ERPs at different stages of the medicine prices according to the WHO/HAI, to examine the contribution of each stage in the supply chain to the final ...

  3. External reference pricing - Wikipedia

    en.wikipedia.org/wiki/External_reference_pricing

    [8]: 302 Furthermore, with the widespread adoption of ERP, pharmaceutical manufacturers are developing counter strategies to limit the negative impacts on them, such as reduced drug prices. [ 8 ] : 302 One strategy is to delay the launch of new drug products into the market, as is the case with Belgium, being usually not among the countries ...

  4. Prescription drug prices in the United States - Wikipedia

    en.wikipedia.org/wiki/Prescription_drug_prices...

    Pharmaceutical companies have also employed the "pay-to-delay" strategy in which they enter into reverse payment agreements with generic companies to delay the generic drug's manufacturer. [58] This was the case in 2008, when an agreement between AstraZeneca and Ranbaxy Laboratories Ltd. ("Ranbaxy") was reached to delay Ranbaxy's launch of a ...

  5. Medication costs - Wikipedia

    en.wikipedia.org/wiki/Medication_costs

    Medication costs can be the selling price from the manufacturer, that price together with shipping, the wholesale price, the retail price, and the dispensed price. [3]The dispensed price or prescription cost is defined as a cost which the patient has to pay to get medicines or treatments which are written as directions on prescription by a prescribers. [4]

  6. 340B Drug Pricing Program - Wikipedia

    en.wikipedia.org/wiki/340B_Drug_Pricing_Program

    The 340B Drug Pricing Program is a US federal government program created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities at significantly reduced prices. The intent of the program is to allow covered entities to "stretch scarce federal resources as far as possible ...

  7. Louis Preston Garrison - Wikipedia

    en.wikipedia.org/wiki/Louis_Preston_Garrison

    Louis Preston Garrison Jr. (born 1950) is an American health economist who has made significant contributions to pharmacoeconomics, pharmacogenomics and personalized medicine, regulatory benefit-risk analysis, insurance, pricing, reimbursement and risk-sharing agreements.

  8. AOL Mail

    mail.aol.com

    Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!

  9. Average wholesale price - Wikipedia

    en.wikipedia.org/wiki/Average_wholesale_price

    In the United States, the average wholesale price (AWP) is a prescription drug term referring to the average price for medications offered at the wholesale level. [1] The metric was originally intended to convey real pricing information to third-party payers, including government prescription drug programs.